05/11/2016. Human urate homeostasis. Tophi and Frequent Gout Flares Are Associated With Impairment to Health Related Quality of Life

Size: px
Start display at page:

Download "05/11/2016. Human urate homeostasis. Tophi and Frequent Gout Flares Are Associated With Impairment to Health Related Quality of Life"

Transcription

1 Prevalence per 1000 inhabitants SF-6D Health Utilities 05/11/2016 Giovambattista Desideri UO Geriatria Università degli Studi dell Aquila Tophi and Frequent Gout Flares Are Associated With Impairment to Health Related Quality of Life 0,8 0,75 0,7 0,688 0,685 L iperuricemia cronica nell anziano con o senza deposito di urati: cause e trattamento 0,65 0,6 0,55 0,5 0,627 0,635 0,45 0,4 RA OA SLE Gout Khanna P et al. Health and Quality of Life Outcomes 2012, 10:117 Epidemiology of gout and hyperuricaemia (SUA >6 mg/dl) in Italy during the years Hyperuricemia Males Hyperuricemia Female Gout Males Gout Females Human urate homeostasis Oxidative stress Humans and higher primates Rest of mammals Uricase over 85 Trifirò G, et al. Ann Rheum Dis (2011). Hediger MA et al. Physiology (Bethesda) Apr;20:

2 Prevalence of gout in men in New Zealand (Maori) compared with men of European descent Associations of purine-rich food groups with gout, from the Health Professionals Follow-up Study (HPFS) Klemp P et al. Ann Rheum Dis 1997;56:22 6; Roddy E et al. Rheumatology 2007;46:1441 4; Lennane GA et al. Ann Rheum Dis 1960;19: Choi HK et al. N Engl J Med. 2004;350: Associations of alcoholic beverages with gout, from the Health Professionals Follow-up Study (HPFS) Summary of the effects of beer, liquor and wine on SUA or gout by study Choi HK et al. Lancet. 2004;363: MacFarlane LA et al. Rheum Dis Clin North Am November ; 40(4):

3 Sugar Sweetened Beverages and Serum Uric Acid levels in Adolescents Vitamin C Intake and Serum Uric Acid Concentration in Men Nguyen S et al. J Pediatr June ; 154(6): Gao X et al. J Rheumatol September ; 35(9): Age- and sex-adjusted serum uric acid levels according to categories of coffee, tea, and caffeine intake: NHANES-III Summary of the effects of diet on risk of gout Vegetable proteins SUA LEVELS Beer, liquor, wine* Meat Seefaood Fructose/sugar -sweetened beverages Dairy Coffe Vitamin C SUA LEVELS cherries Choi HK et al. Arthritis Rheum Jun 15;57(5): MacFarlane LA et al. Rheum Dis Clin North Am November ; 40(4):

4 Dose-Response Association and CVD risk factors with Hyperuricemia Effects on Uric Acid Metabolism of the Drugs Drugs that lower serum uric acid Drugs that raise serum uric acid Juraschek SP et al. PLoS One. 2013;8(2):e Moriwaki, J Bioequiv Availab 2014, 6:1 The therapeutical management of chronic hyperuricemia in the third millennium What we would like to treat/prevent by urate lowering treatment? Flares, tophi, nephrolithiasis and subclinical damage? Cardio-nephro-metabolic protection (?) How we can reduce serum uric acid? Lifestyle Drugs The therapeutical management of chronic hyperuricemia in the third millennium What we would like to treat/prevent by urate lowering treatment? Flares, tophi, nephrolithiasis and subclinical articular damage? Cardio-nephro-metabolic protection (?) How we can reduce serum uric acid? Lifestyle Drugs 4

5 Gout: The Fashionable Disease Likelyhood ratio for various features in the diagnosis of gout - EULAR "the disease of kings "rich man's disease Ann Rheum Dis 2006;65: Gout in the elderly: (a)tipical features Gout is one of the most painful type of arthritis However, gout in the elderly tend to be more indolent while gout flares tend to be more polyarticular Given the chronicity of gout, elderly patients tend to have an increased incidence of tophi, especially of the elbows and hands Gout in the Elderly can be mistaken for changes that are usually attributed to OA or RA The presence of tophi in the hands and the upper extremities can be mistaken for rheumatoid nodules. Tophi can supervene on Heberdenʼs and Bouchardʼs nodes. 5

6 Asymptomatic articular damage in hyperuricemia Asymptomatic articular damage in hyperuricemia Musculoskeletal US can be able to visualize intraarticular crystal deposits with a characteristic hyperechoic enhancement of the outer surface of the hyaline cartilage, known as the double contour sign. Pineda et al. Arthritis Research & Therapy 2011, High Serum Uric Acid Hyperuricemia and gout: time for a new staging system? The therapeutical management of chronic hyperuricemia in the third millennium A proposed revised staging system for hyperuricaemia and gout, based on the American Heart Association heart failure staging system. What we would like to treat/prevent by urate lowering treatment? Flares, tophi, nephrolithiasis and subclinical articular damage Cardio-nephro-metabolic protection (?) How we can reduce serum uric acid? Lifestyle Drugs Dalbeth N et al. Ann Rheum Dis

7 Prevalence per 1000 inhabitants ASYMPTOMATIC HYPERURICEMIA 05/11/2016 Epidemiology of gout and hyperuricaemia (SUA >6 mg/dl) in Italy during the years Hyperuricemia and CV disease Hyperuricemia Males Hyperuricemia Female Gout Males Gout Females over 85 Trifirò G, et al. Ann Rheum Dis (2011). High Serum Uric Acid Determinants of Hyperuricemia Xanthine oxydase Hypertension Modified from Rees F et al. Nat. Rev. Rheumatol. doi: /nrrheum

8 Determinants of Hyperuricemia L iperuricemia induce lo sviluppo di arteriolosclerosi in modo indipendente dalla pressione arteriosa. Xanthine oxydase excretion production Modified from Rees F et al. Nat. Rev. Rheumatol. doi: /nrrheum Mazzali et al, AJP Renal Physiol, 2002 Inflammasome: the missing link between gout and cardio-nephro-metabolic disorders? Inflammasome: the missing link between gout and cardio-nephro-metabolic disorders? 8

9 Hyperuricemia and Cardiorenal Metabolic Syndrome Alexander the great, Darwin, Harvey, Newton, Sydenham,. This association cannot be mere co-incidence. Chaudhary K et al Cardiorenal Med 2013;3: Study of Serum Uric Acid and its Correlation with Intelligence Quotient and Other Parameters in Normal Healthy Adults Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society? 100 medical students in the age group of 17 to 20 years Uric acid having similar structure to that of caffeine and theobromine acts as a cerebral caffeine stimulant and thought to be responsible for better development of brain and more intelligence 1. Uric acid can increase locomotor activity in rats 2 Uric acid increases with emotional or physical stress 3 1 Orowan E. Nature 1955;175: Barrea CM et al. Pharmacol Biochem Behav1989;33: Patil U et al. International Journal of Recent Trends in Science And Technology Rahe RH et al. Psychosom Med 1974;36: Johnson RJ et al. J Comp Physiol B (1):

10 Uric Acid and Dementia in Community-Dwelling Older Persons: The InChianti Study elderly subjects (age 74.38±7.58 years) Cerebral Ischemia Mediates the Effect of Serum Uric Acid on Cognitive Function Mean age, 59.9±18.9 mg/dl Serum UA, 4.5±1.4 mg/dl 108 community-dwelling adults aged 20 to 96 years Adjusted for UA tertile OR p age, sex, BMI, education 1) 3.82±0.53 mg/dl 2) 5.05±0.27 mg/dl 3) 6.72±1.24 mg/dl 1 (reference) 2.34 ( ) 3.06 ( ) alchohol, energy intake, smoking, chol, plasma vit. E 1) 3.82±0.53 mg/dl 2) 5.05±0.27 mg/dl 3) 6.72±1.24 mg/dl 1 (reference) 2.73 ( ) 3.63 ( ) renal function, hypertension, CVD, CBVD 1) 3.82±0.53 mg/dl 2) 5.05±0.27 mg/dl 3) 6.72±1.24 mg/dl 1 (reference) 2.62 ( ) 3.32 ( ) WM PS IF VeM WM PS IF VeM + MMSE basal score 1) 3.82±0.53 mg/dl 2) 5.05±0.27 mg/dl 3) 6.72±1.24 mg/dl 1 (reference) ( ) ( ) Ruggiero C, et al. Dement Geriatr Cogn Disord 2009;27: Vannorsdall TD, et al. Stroke. 2008;39: Could uric acid directly promote neuronal dysfunction and/or damage? 10

11 Ambivalenza biologica dell acido urico The therapeutical management of chronic hyperuricemia in the third millennium What we would like to treat/prevent by urate lowering treatment? Flares, tophi, nephrolithiasis and subclinical articular damage Cardio-nephro-metabolic protection (?) How we can reduce serum uric acid? Lifestyle Drugs Therapeutic Approaches to Chronic Hyperuricemia and Gout Patient education and appropriate lifestyle advice (healthy diet and reduced consumption of beverages containing fructose and alcohol, beer especially) are core aspects of management. Strength of recommendation (95% CI): 83 (75, 91) Charles Dickens wrote about gout in both Bleak House and The Pickwick Papers. In The Pickwick Papers, the character Sam Weller warns his father that drinking will lead to gout. Manara M et al. Reumatismo, 2013; 65 (1): 4-21 Desideri G et al. High Blood Press Cardiovasc Prev (2014) 21:

12 Percentage of Subjects With SUA <6.0 mg/dl Prevalence (%) Proportion of patients (%) 05/11/2016 The purine degradation pathway Allopurinol- and Placebo-Controlled, Efficacy Study of Febuxostat: APEX study Subjects (n =1.072) with serum urate level >8.0 mg/dl and gout and normal or impaired RF (creat. >1.5 to <2.0 mg/dl) / /262 ᵃ ᵇ ᶜ 4/9 170/ /269 ᵃ ᵇ 5/11 Patients with Normal Renal Function Patients with Impaired Renal Function Ten patients received 100 mg and 258 subjects received 300 mg of allopurinol based on renal function. a = p < 0.05 versus allopurinol in patients with impaired renal function; b = p < versus allopurinol in all patients; c = p < versus febuxostat 120 mg in all patients. 60/ / Allopurinol Febuxostat Berry CE et al. J Physiol. 2004; 555(Pt 3): Febuxostat 80 mg (n=262) _ Febuxostat 120 mg (n=269) _ 0/10 Allopurinol 300 mg * (n=268) _ Becker MA et al. Arthritis Research & Therapy 2010; 12: R63. Efficacy and Safety of Febuxostat for Urate Lowering in Gout Patients >65 Years of Age Elderly Subjects Often Have a Great Frequency of Comorbidities and Are Taking Multuple Drugs b,c d a p=0.029 vs allopurinol b p<0.001 vs febuxosta 40 mg c p<0.001 vs allopurinol d p=0.004 vs allopurinol b,c a Jackson RL et al. BMC Geriatrics 2012;12:11 Jackson RL et al. BMC Geriatrics 2012;12:11 12

13 Systolic Blood Pressure (mmhg) Systolic Blood Pressure (mmhg) Diastolic Blood Pressure (mmhg) Diastolic Blood Pressure (mmhg) Prevalence (%) 05/11/2016 Selected concomitant medication use among elderly subjects during the CONFIRMS trial Febuxostat is an effective alternative to allopurinol which shows greater efficacy and minor adverse effects as urate lowering agent. Starting doses are to be low and increased if necessary. Strength of recommendation (95% CI): 82 (76, 89) Jackson RL et al. BMC Geriatrics 2012;12:11 Effect of Uric Acid Lowering on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension Mean 24 hour blood pressure IMPORTANT QUESTIONS What threshold should be adopted to define hyperuricemia? Is hyperuricemia an independent risk factor for cardiovascular disease? Can we improve cardiovascular and renal outcomes by lowering sua levels? Pretreatment End of placebo phase Pretreatment End of allopurinol phase Pretreatment End of placebo phase Pretreatment End of allopurinol phase When should urate-lowering therapy be started? Borghi C et al. J Hypertens 2015;33: Feig DI et al. JAMA. 2008;27;300(8):

14 Comparison of randomized studies using xanthine oxidase inhibition in heart failure Reaction scheme for the XO- mediated conversion of hypoxanthine to UA and suicide inhibitor allopurinol to the dead end inhibitor, oxypurinol Tamariz L. et al. Circulation April Allopurinol inhibits uric acid formation but produces ROS Tamta H et al. Biochemistry 2006;71 Suppl 1:S Reaction scheme for the XO- mediated conversion of hypoxanthine to UA and suicide inhibitor allopurinol to the dead end inhibitor, oxypurinol Allopurinol and Cardiovascular Outcomes in Adults With Hypertension A total of 2032 allopurinol-exposed patients and 2032 matched nonexposed patients were studied: 10-year period Malik UZ et al. Free Radic Biol Med. 2011Jul 1;51(1): Allopurinol inhibits uric acid formation but produces ROS Tamta H et al. Biochemistry 2006;71 Suppl 1:S MacIsaac ML et al. Hypertension

15 Mean annual hospitalizations costs ( ) Mean annual total costs ( ) 05/11/2016 Febuxostat: RCT with CV outcome Trial Drug 1 objective Reference BP control Coronary endothelial dysfunction BP control Exercise tolerance in chronic angina Febuxostat vs. Allopurinol Febuxostat vs. Placebo Febuxostat vs. Placebo Febuxostat vs.placebo Clinic and ABPM Coronary flow ABPM Exercise test (ETT) NCT NCT NCT NCT ClinicalTrial.gov Total health care resource costs according to SUA levels Outpa ent Services Hospitaliza on Pharmaceu cal <=6 >6 <=7 >7 <=8 >8 Degli Esposti L et al, NMCD 2016 Total hospitalization costs according to SUA levels 2014 EULAR recommendations on the management of gout Other Hyperuricemia, kidney disease and CVD Recommendation 11: (ULT) Median: 9; min: 8; max: 9 All ULT should be started at a low dose and subsequently titrated upwards until the SUA target is reached. SUA below 6 mg/dl (360 µmol/l) should be maintained lifelong CV mortality 0 <=6 >6 <=7 >7 <=8 >8 Stack AG et al. QJM 2013; 106: Degli Esposti L et al, NMCD

La gestione dell iperuricemia cronica con e senza deposito di urato nell anziano tra clinica e farmacoeconomia

La gestione dell iperuricemia cronica con e senza deposito di urato nell anziano tra clinica e farmacoeconomia Giovambattista Desideri UO Geriatria Università degli Studi dell Aquila Simposio: Dismetabolismo dell acido urico: quali novità per il geriatra? La gestione dell iperuricemia cronica con e senza deposito

More information

Iperuricemia nell anziano: dal danno articolare al deterioramento cognitivo

Iperuricemia nell anziano: dal danno articolare al deterioramento cognitivo Iperuricemia nell anziano: dal danno articolare al deterioramento cognitivo Giovambattista Desideri Unità Operativa e SS di Geriatria Università degli Studi Dell Aquila Prevalence per 1000 inhabitants

More information

Insidie del binomio iperuricemia e rischio CV

Insidie del binomio iperuricemia e rischio CV Insidie del binomio iperuricemia e rischio CV Claudio Borghi, FESC, FAHA Department of Medical and Surgical Sciences University of Bologna, Bologna, Italy Claudio Borghi Potential conflicts of interest

More information

Uricemia nei pazienti a. fattore o marker di rischio? Claudio Borghi, FESC, FAHA Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna

Uricemia nei pazienti a. fattore o marker di rischio? Claudio Borghi, FESC, FAHA Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna Uricemia nei pazienti a rischio CV: fattore o marker di rischio? Claudio Borghi, FESC, FAHA Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna R.Magritte: La reproducion interdite Urate

More information

Gout -revisited. Shrenik Shah

Gout -revisited. Shrenik Shah Gout -revisited Shrenik Shah definition Monosodium urate (MSU) crystal deposition episodic and later persistent joint inflammation and tophi All MSU crystal deposition- broader definition EULAR- European

More information

Fructose, Uric Acid and Hypertension in Children and Adolescents

Fructose, Uric Acid and Hypertension in Children and Adolescents Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion

More information

Update on Gout for GPs

Update on Gout for GPs Update on Gout for GPs Dr Patrick Kiely PhD FRCP Consultant Physician and Rheumatologist St George s, London 2/3 1/3 Gut bacteria have uricase Chronic erosive arthropathy Clinical spectrum Making the diagnosis

More information

Gout: Update in therapeutics

Gout: Update in therapeutics Summary Gout: Update in therapeutics 29/11/14 Caroline van Durme CHU de Liège Maastricht University Medical Centre+ Why treating gout? Guidelines: ACR 12 Drugs: Colchicine Allopurinol: what about the kidney?

More information

1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout

1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout Objectives 1. To review the diagnosis of gout and its differential GOUT 2. To understand the four stages of gout 3. To develop an approach for the acute treatment of gout Anthony Lim 9/13/12 Cycle 3 4.

More information

Gout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy

Gout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy Gout 2.0 Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy Case 48 year old man presents with swollen, painful left toe that started overnight. Didn t hurt when he went to bed. No

More information

Rheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy

Rheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy Rheumatoid arthritis, seronegative spondylarthritides and gout György Nagy Dec 4, 2017 Rheumatoid arthritis Rheumatoid arthritis Chronic, progressive, autoimmune disorder of the joints with extra-articular

More information

Gout A rapid review. Jeremy Jones

Gout A rapid review. Jeremy Jones Gout A rapid review Jeremy Jones The Hyperuricemia Cascade Dietary purines Tissue nucleic acids Urate Endogenous purine synthesis Overproduction Hyperuricemia Underexcretion Silent tissue deposition Gout

More information

GOUT. Dr Krishnan Baburaj West herts NHS Trust

GOUT. Dr Krishnan Baburaj West herts NHS Trust GOUT Dr Krishnan Baburaj West herts NHS Trust podagra Gout A disease of kings, the king of diseases History Louis XIV Emperor Augustus Henry VIII Introduction Gout an inflammatory arthritic condition that

More information

Dr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.

Dr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey. The uric acid dilemma: causal risk factor for hypertension and CKD or mere bystander? Mehmet Kanbay, Istanbul, Turkey Chairs: Anton H. van den Meiracker, Rotterdam, The Netherlands Claudia R.C. Van Roeyen,

More information

Uloric Step Therapy Program

Uloric Step Therapy Program Uloric Step Therapy Program Policy Number: 5.01.584 Last Review: 7/2017 Origination: 7/2014 Next Review: 7/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for brand

More information

Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout

Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout Philippine Journal of Internal Medicine Meta-Analysis Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout Erika Bianca S. Villazor-Isidro, M.D.*; John Carlo G.

More information

Case presentation. serum uric acid = 11.5 mg/dl 24-hour uric acid excretion = 300 mg

Case presentation. serum uric acid = 11.5 mg/dl 24-hour uric acid excretion = 300 mg GOUT 55 y/o male 12 hours pain in my big toe & ankle went to bed last night feeling fine felt as if had broken toe this morning similar problems in right ankle & left wrist Case presentation lab studies

More information

Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP

Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP Dr. Paul Doghramji is attending physician at the Pottstown Memorial Medical Center and medical director of Health Services

More information

An update on the management of gout

An update on the management of gout An update on the management of gout 8 The management of gout involves treatment of an acute attack, lifestyle modification and urate lowering treatment to achieve a target serum urate level. Recent evidence

More information

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George Uric acid and CKD Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George Hospital @Badves Case Mr J, 52 Male, referred in June 2015 DM type 2 (4 years), HTN, diabetic retinopathy, diabetic

More information

Gout Hanan Abdel Rehim

Gout Hanan Abdel Rehim Review article 35 Gout Hanan Abdel Rehim Department of Internal Medicine, Kasr-Al Aini School of Medicine, Cairo University, Cairo, Egypt Correspondence to Hanan Abdel Rehim, MD, 11 Ismaiel Wahby Street,

More information

Sessione Congiunta SIMDO - FADOI. Acido urico e diabete: quando e come correggere

Sessione Congiunta SIMDO - FADOI. Acido urico e diabete: quando e come correggere Sessione Congiunta SIMDO - FADOI Acido urico e diabete: quando e come correggere Giovanni Gulli ASL CN1 SC Medicina Interna Ospedale Maggiore SS. Annunziata Savigliano, CN Agenda uric acid (UA) metabolism

More information

Cost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout

Cost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout Cost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout The NCPE has issued a recommendation regarding the cost-effectiveness of Lesinurad (Zurampic ) in combination with

More information

A Patient s Guide to Gout. Foot and Ankle Center of Massachusetts, P.C.

A Patient s Guide to Gout. Foot and Ankle Center of Massachusetts, P.C. A Patient s Guide to Gout Welcome to Foot and Ankle Center of Massachusetts, where we believe in accelerating your learning curve with educational materials that are clearly written and professionally

More information

CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial)

CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial) CARDIOVASCULAR SAFETY OF FEBUXOSTAT OR ALLOPURINOL IN PATIENTS WITH GOUT AND CARDIOVASCULAR DISEASE (The CARES Trial) William B. White, MD for the CARES Investigators Calhoun Cardiology Center University

More information

Study of Serum Uric Acid Level in Adolescents Who Were Born Preterm

Study of Serum Uric Acid Level in Adolescents Who Were Born Preterm International Journal of Biotechnology and Biochemistry ISSN 0973-2691 Volume 14, Number 3 (2018) pp. 193-197 Research India Publications http://www.ripublication.com Study of Serum Uric Acid Level in

More information

COMPARATIVE EVALUATION OF EFFICACY AND SAFETY PROFILE OF FEBUXOSTAT WITH ALLOPURINOL IN PATIENTS WITH HYPERURICEMIA AND GOUT

COMPARATIVE EVALUATION OF EFFICACY AND SAFETY PROFILE OF FEBUXOSTAT WITH ALLOPURINOL IN PATIENTS WITH HYPERURICEMIA AND GOUT Int. J. Pharm. Med. & Bio. Sc. 2013 P K Agarwal and Bijay Kumar, 2013 Research Paper ISSN 2278 5221 www.ijpmbs.com Vol. 2, No. 4, October 2013 2013 IJPMBS. All Rights Reserved COMPARATIVE EVALUATION OF

More information

THE ROLE OF URIC ACID IN THE PROGRESSION OF CKD Mehmet Kanbay, Istanbul, Turkey

THE ROLE OF URIC ACID IN THE PROGRESSION OF CKD Mehmet Kanbay, Istanbul, Turkey THE ROLE OF URIC ACID IN THE PROGRESSION OF CKD Mehmet Kanbay, Istanbul, Turkey Chairs: Gerjan Navis, Groningen, The Netherlands Kamil Serdengecti, Istanbul, Turkey Dr. M. Kanbay Division of Nephrology

More information

Zurampic. (lesinurad) New Product Slideshow

Zurampic. (lesinurad) New Product Slideshow Zurampic (lesinurad) New Product Slideshow Introduction Brand name: Zurampic Generic name: Lesinurad Pharmacological class: URAT1 inhibitor Strength and Formulation: 200mg; tablets Manufacturer: Ironwood

More information

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular Health Christina M. Shay, PhD, MA 1 Presenter Disclosure Information Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular

More information

Gout. Edward Roddy, 1 Christian D Mallen, 1 Michael Doherty 2 CLINICAL REVIEW

Gout. Edward Roddy, 1 Christian D Mallen, 1 Michael Doherty 2 CLINICAL REVIEW Gout Edward Roddy, 1 Christian D Mallen, 1 Michael Doherty 2 1 Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele ST5 5BG, UK 2 Academic Rheumatology, University

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

New Drug Evaluation: lesinurad tablet, oral

New Drug Evaluation: lesinurad tablet, oral Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Lecture 8 Gout Hinch. Pathogenesis of acute attacks

Lecture 8 Gout Hinch. Pathogenesis of acute attacks Gout: disease characterized by deposition of monosodium crystals in soft tissues (cartilage, tendons, bursa) recurrent episodes of acute joint pain & inflammation Pathogenesis of acute attacks Epidemiology:

More information

Chronic Ischemic Cardiomiopathy: RISK OF CARDIOVASCULAR DEATH AND URIC ACID

Chronic Ischemic Cardiomiopathy: RISK OF CARDIOVASCULAR DEATH AND URIC ACID Sebastiano MARRA MD,FESC DIRECTOR CARDIOVASCULAR and THORACIC DIPARTMENT Chronic Ischemic Cardiomiopathy: RISK OF CARDIOVASCULAR DEATH AND URIC ACID NO CONFLITS OF INTEREST Dr. Nathan Smith Davis Am Medical

More information

Prevalence of Gout and Hyperuricemia in the US General Population

Prevalence of Gout and Hyperuricemia in the US General Population ARTHRITIS & RHEUMATISM Vol. 63, No. 10, October 2011, pp 3136 3141 DOI 10.1002/art.30520 2011, American College of Rheumatology Prevalence of Gout and Hyperuricemia in the US General Population The National

More information

Enhanced Primary Care Pathway: Gout

Enhanced Primary Care Pathway: Gout Enhanced Primary Care Pathway: Gout 1. Focused summary of gout relevant to primary care Significance: Gout is a chronic, progressive, inflammatory disease requiring appropriate long-term management. Gout

More information

Gout: Let s Be Crystal Clear. Dr. Philip A. Baer Seacourses Asia CME December 2017

Gout: Let s Be Crystal Clear. Dr. Philip A. Baer Seacourses Asia CME December 2017 Gout: Let s Be Crystal Clear Dr. Philip A. Baer Seacourses Asia CME December 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or

More information

Long-term Treatment of Gout: New Opportunities for Improved Outcomes

Long-term Treatment of Gout: New Opportunities for Improved Outcomes Long-term Treatment of Gout: New Opportunities for Improved Outcomes Paul P. Doghramji, MD, FAAFP CONTINUING MEDICAL EDUCATION LEARNING OBJECTIVES Make a presumptive diagnosis of gout based on history

More information

Study of Febuxostat for the Management of Hyperuricemia in Gout

Study of Febuxostat for the Management of Hyperuricemia in Gout Human Journals Review Article October 2015 Vol.:4, Issue:3 All rights are reserved by Sachin S. Shinde et al. Study of Febuxostat for the Management of Hyperuricemia in Gout Keywords: Febuxostat, Hyperuricemia,

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

Gout. Clinical features Most commonly affects middle-aged males. It is an acute and usually relapsing selflimiting

Gout. Clinical features Most commonly affects middle-aged males. It is an acute and usually relapsing selflimiting Gout Gout is a syndrome caused by an inflammatory response to the formation of monosodium urate monohydrate crystals which develop secondary to hyperuricemia. Acute and chronic forms are recognized. Hyperuricemia

More information

Crystal-Induced Arthritis. Rajesh Kataria, D.O. Southern Ohio Rheumatology

Crystal-Induced Arthritis. Rajesh Kataria, D.O. Southern Ohio Rheumatology Crystal-Induced Arthritis Rajesh Kataria, D.O. Southern Ohio Rheumatology Disclosures Speaker: Rajesh Kataria, D.O. Relationships with commercial interests: Speakers Bureau - Horizon Presentation will

More information

pegloticase (Krystexxa )

pegloticase (Krystexxa ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Rheumatology Cases for the Internist

Rheumatology Cases for the Internist Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School

More information

Gout basics. Update on Gout. Production of uric acid. Gout basics. Crystal induced inflammation. Gout calculator. The important role of ultrasound

Gout basics. Update on Gout. Production of uric acid. Gout basics. Crystal induced inflammation. Gout calculator. The important role of ultrasound Update on Gout The important role of ultrasound Cheung C Yue, M.D. Gout basics Hyperuricemia gout Over 5 years, 22% >9 mg/dl develop gout Man 3-4 times more than women Risks: thiazide, cyclosporin, low

More information

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Gout and Pseudogout Wayne Blount MD Speaker has no disclosures

More information

OBJECTIVES GOUT GOUTY INFLAMMATION 6/10/2016 GOUT INCIDENCE AND PREVALENCE MONOSODIUM URATE CRYSTAL DEPOSITION DISEASE

OBJECTIVES GOUT GOUTY INFLAMMATION 6/10/2016 GOUT INCIDENCE AND PREVALENCE MONOSODIUM URATE CRYSTAL DEPOSITION DISEASE GOUT Lisa Talbert, MD Family Medicine Update June 15, 2016 OBJECTIVES To be familiar with the clinical presentation and pathophysiology of gouty arthritis Be able to incorporate current guidelines when

More information

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES Generic Brand HICL GCN Exception/Other PEGLOTICASE KRYSTEXXA 37154 GUIDELINES FOR USE 1. Does the patient have a diagnosis of symptomatic chronic gout (prior to initiating Krystexxa therapy) with clinical

More information

Clinical Biochemistry department/ College of medicine / AL-Mustansiriyah University

Clinical Biochemistry department/ College of medicine / AL-Mustansiriyah University Clinical Biochemistry department/ College of medicine / AL-Mustansiriyah University Dr. Ali al-bayati NUCLEOTIDE METABOLISM Lec. 3 The salvage pathway of purine synthesis Purines that result from the normal

More information

Febuxostat: a safe and effective therapy for hyperuricemia and gout

Febuxostat: a safe and effective therapy for hyperuricemia and gout DRUG EVALUATIO Febuxostat: a safe and effective therapy for hyperuricemia and gout atasha Jordan & Geraldine M McCarthy Author for correspondence Mater Misericordiae University Hospital, Eccles St. Dublin

More information

Febuxostat: a new treatment for hyperuricaemia in gout

Febuxostat: a new treatment for hyperuricaemia in gout Rheumatology 2009;48:ii15 ii19 doi:10.1093/rheumatology/kep088 Febuxostat: a new treatment for hyperuricaemia in gout N. Lawrence Edwards 1 Febuxostat is a new non-purine xanthine oxidase inhibitor that

More information

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk Send Orders of Reprints at reprints@benthamscience.net 2432 Current Pharmaceutical Design, 2013, 19, 2432-2438 Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk Davide Grassi, Livia Ferri

More information

A study to assess relationship between Uric Acid and Blood pressure among patients attending tertiary care hospital in Central Gujarat

A study to assess relationship between Uric Acid and Blood pressure among patients attending tertiary care hospital in Central Gujarat ORIGINAL ARTICLE A study to assess relationship between Uric Acid and Blood pressure among patients attending tertiary care hospital in Central Gujarat Meenakshi Shah 1, Varsha Godbole 2, Upesh Parmar

More information

RE: Manuscript ID BMJ

RE: Manuscript ID BMJ February 17, 2017 Dr. Daoxin Yin Editorial Office, BMJ RE: Manuscript ID BMJ.2016.036557 Dear Dr. Yin: Thank you for your interest in our manuscript The Dietary Approaches to Stop Hypertension Diet, Western

More information

COPYRIGHT. Update in Internal Medicine December 4, 2016

COPYRIGHT. Update in Internal Medicine December 4, 2016 Update in Internal Medicine December 4, 2016 Fadi Badlissi, MD, MSc Director of the Musculoskeletal Medicine Unit The Orthopedic Department & Rheumatology Division Beth Israel Deaconess Medical Center

More information

Podcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam. Howard J. Sachs, MD

Podcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam. Howard J. Sachs, MD Podcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam Howard J. Sachs, MD www.12daysinmarch.com Email: Howard@12daysinmarch.com Podcast (Video Recorded Lecture Series): Gout for the

More information

Lesinurad in Combination With a Xanthine Oxidase Inhibitor for Treatment of Hyperuricemia Associated With Gout

Lesinurad in Combination With a Xanthine Oxidase Inhibitor for Treatment of Hyperuricemia Associated With Gout Lesinurad in Combination With a Xanthine Oxidase Inhibitor for Treatment of Hyperuricemia Associated With Gout Briefing Document for the Arthritis Advisory Committee Meeting Date: 23 October 215 Ardea

More information

CHAPTER:2 GOUT. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:2 GOUT. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:2 GOUT BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY DEFINITION Gout is defined as a peripheral arthritis, resulting from the deposition of MSU crystals

More information

Johannes Nossent 1,2*, Warren Raymond 1, Mark Divitini 3 and Matthew Knuiman 3

Johannes Nossent 1,2*, Warren Raymond 1, Mark Divitini 3 and Matthew Knuiman 3 Nossent et al. BMC Cardiovascular Disorders (2016) 16:256 DOI 10.1186/s12872-016-0421-1 RESEARCH ARTICLE Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall

More information

What will happen in the future? How will gout be diagnosed? How is gout treated? prevent

What will happen in the future? How will gout be diagnosed? How is gout treated? prevent Rheumatology Day Unit Dr J Hamilton 0191 4458359 0191 4455240 (9-5 Mon-Fri) Dr C Heycock 0191 4452198 Answer phone on 24hours Dr C Kelly 0191 4452193 Dr V Saravanan 0191 4456055 Dr M Rynne 0191 4458359

More information

Gout- Treatment Updates. Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA

Gout- Treatment Updates. Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA Gout- Treatment Updates Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA Gout Outline of purine metabolism: (1) amidophosphoribosyltransferase (2) hypoxanthine-guanine phosphoribosyltransferase

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/

More information

Managing Gout A Review of the Research for Adults

Managing Gout A Review of the Research for Adults Managing Gout A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional* has said that you have gout. You are age 18 or

More information

Journal of Advanced Scientific Research

Journal of Advanced Scientific Research Bijoy Kumar Panda et al, J Adv Scient Res, 2012, 3(2): 03-11 3 Journal of Advanced Scientific Research Available online through http://www.sciensage.info/jasr ISSN 0976-9595 Review Article Febuxostat,

More information

Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK

Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK Examining the relationship between beverage intake and cardiovascular health Ian Macdonald University of Nottingham UK Outline Assessment of evidence in relation to health risks of dietary components Cardiovascular

More information

Current treatment options for acute and chronic gout

Current treatment options for acute and chronic gout DRUG REVIEW n Current treatment options for acute and chronic gout Kelsey Jordan FRCP and Andrew Jeffries PGDip, MRCP Gout is the only curable form of arthritis, yet only a third of patients with chronic

More information

How toxic is uric acid? Elisabetta Toso, MD Città della Salute e della Scienza di Torino Cardiology Division, University of Turin

How toxic is uric acid? Elisabetta Toso, MD Città della Salute e della Scienza di Torino Cardiology Division, University of Turin How toxic is uric acid? Elisabetta Toso, MD Città della Salute e della Scienza di Torino Cardiology Division, University of Turin Uric acid is a heterocyclic compound of carbon, nitrogen, oxygen and hydrogen.

More information

Subject: Krystexxa (pegloticase) Original Effective Date: 06/26/13. Policy Number: MCP-138. Revision Date(s):

Subject: Krystexxa (pegloticase) Original Effective Date: 06/26/13. Policy Number: MCP-138. Revision Date(s): Subject: Krystexxa (pegloticase) Original Effective Date: 06/26/13 Policy Number: MCP-138 Revision Date(s): Review Date(s): 12/16/15; 6/15/2016; 3/21/2017 DISCLAIMER This Molina Clinical Policy (MCP) is

More information

Women With Gout: Efficacy and Safety of Urate-Lowering With Febuxostat and Allopurinol

Women With Gout: Efficacy and Safety of Urate-Lowering With Febuxostat and Allopurinol Arthritis Care & Research Vol. 64, No. 2, February 2012, pp 256 261 DOI 10.1002/acr.20680 2012, American College of Rheumatology ORIGINAL ARTICLE Women With Gout: Efficacy and Safety of Urate-Lowering

More information

Febuxostat now subsidised on Special Authority

Febuxostat now subsidised on Special Authority Gout update: Febuxostat now subsidised on Special Authority 38 Febuxostat was added to the New Zealand Pharmaceutical Schedule on 1 June, 2014. It is now available as a third-line preventive treatment

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 24 June 2009

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 24 June 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 24 June 2009 ADENURIC 80 mg, film-coated tablets B/28 (CIP code: 385 724-4) B/84 (CIP code: 572 820-3) ADENURIC 120

More information

GOUT IN THE ELDERLY. Learning Objectives. Disclosure. Geriatric Grand Rounds. Geriatric Grand Rounds

GOUT IN THE ELDERLY. Learning Objectives. Disclosure. Geriatric Grand Rounds. Geriatric Grand Rounds Visit web sites: Tuesday, June 2, 2009 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this event

More information

Novel uricosurics RHEUMATOLOGY. Thomas Bardin 1,2 and Pascal Richette 1,2. Abstract. Introduction REVIEW

Novel uricosurics RHEUMATOLOGY. Thomas Bardin 1,2 and Pascal Richette 1,2. Abstract. Introduction REVIEW RHEUMATOLOGY Rheumatology 2018;57:i42 i46 doi:10.1093/rheumatology/kex433 Novel uricosurics Thomas Bardin 1,2 and Pascal Richette 1,2 REVIEW Abstract Objective. According to recent guidelines, the mainstay

More information

GOUT GO FOR SIX WITH. Everything You Need to Know About Gout & Uric Acid PLUS:

GOUT GO FOR SIX WITH. Everything You Need to Know About Gout & Uric Acid PLUS: GO FOR SIX WITH Everything You Need to Know About Gout & Uric Acid GOUT PLUS: How to gain control of symptoms A gout-friendly eating style Medication recommendations to discuss with your doctor Lifestyle

More information

Nutritional Epidemiology in the Genomic Age. V. Saroja Voruganti, PhD Assistant Professor Department of Nutrition UNC Nutrition Research Institute

Nutritional Epidemiology in the Genomic Age. V. Saroja Voruganti, PhD Assistant Professor Department of Nutrition UNC Nutrition Research Institute Nutritional Epidemiology in the Genomic Age V. Saroja Voruganti, PhD Assistant Professor Department of Nutrition UNC Nutrition Research Institute Nutritional Epidemiology If we could give every individual

More information

What s In the New Hypertension Guidelines?

What s In the New Hypertension Guidelines? American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the

More information

Gout Goals Are Not Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools TM JointsAflame

Gout Goals Are Not Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools TM JointsAflame Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance QS Priorities Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance Paul P. Doghramji, MD, FAAFP

More information

MEDICAL POLICY PEGLOTICASE (KRYSTEXXA ) POLICY NUMBER MP POLICY TITLE. Original Issue Date (Created): January 1, 2011

MEDICAL POLICY PEGLOTICASE (KRYSTEXXA ) POLICY NUMBER MP POLICY TITLE. Original Issue Date (Created): January 1, 2011 Original Issue Date (Created): January 1, 2011 Most Recent Review Date (Revised): September 24, 2013 Effective Date: November 1, 2013 I. POLICY PREAUTHORIZATION REQUIRED Note: Requests for pegloticase

More information

New Drug Evaluation: lesinurad tablet, oral

New Drug Evaluation: lesinurad tablet, oral Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Vitamin C and Joint Disease. Eva Star FCS 308

Vitamin C and Joint Disease. Eva Star FCS 308 Vitamin C and Joint Disease Eva Star FCS 308 Fall, 2009 Vitamin C and Joint Disease Joint disease affects numerous people around the world. Osteoarthritis is one type of join disease which affects joints

More information

Diagnosis and Management of Gout in 2011

Diagnosis and Management of Gout in 2011 October 18, 2011 Early and accurate gout diagnosis and disease management are essential. Making the clinical diagnosis takes into consideration the differential diagnosis supported by the use of clinical,

More information

Michael H. Pillinger, M.D., David S. Goldfarb, M.D., and Robert T. Keenan, M.D., M.P.H.

Michael H. Pillinger, M.D., David S. Goldfarb, M.D., and Robert T. Keenan, M.D., M.P.H. 199 Gout and Its Comorbidities Michael H. Pillinger, M.D., David S. Goldfarb, M.D., and Robert T. Keenan, M.D., M.P.H. Abstract Gout is a chronic disease in which excessively high levels of serum urate

More information

VI.2 Elements for a Public Summary. VI.2.1 Overview of disease epidemiology

VI.2 Elements for a Public Summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Febuxostat is a medicine used in adults with gout to reduce high levels of uric acid in the blood. Gout results from a build up

More information

Gout: Develop treatment plan in William Jones, MS, RPh

Gout: Develop treatment plan in William Jones, MS, RPh Gout: Develop treatment plan in 2013 William Jones, MS, RPh (wnjones49@cox.net) Objectives Describe acute gouty arthritis Tx Describe Tx of chronic gouty arthritis. Define the target serum uric acid concentration

More information

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal

More information

Disclosures. Ultrasonography. Conventional radiography (XR) Magnetic resonance imaging. Conventional CT 10/27/2013

Disclosures. Ultrasonography. Conventional radiography (XR) Magnetic resonance imaging. Conventional CT 10/27/2013 What I can see in my gout patient that I couldn t before: the role of advanced imaging in gout diagnosis and monitoring Disclosures ND is supported by the Health Research Council of New Zealand I have

More information

DEPARTMENT OF GENERAL MEDICINE WELCOMES

DEPARTMENT OF GENERAL MEDICINE WELCOMES DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global

More information

Gout Treatment Guidelines

Gout Treatment Guidelines Gout Treatment Guidelines Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia,

More information

Gout Goals Are Not Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools JointsAflame

Gout Goals Are Not Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools JointsAflame Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance QS Priorities Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools TM JointsAflame

More information

Managing High Blood Pressure Naturally. Michael A. Smith, MD Life Extension s Healthy Talk Series

Managing High Blood Pressure Naturally. Michael A. Smith, MD Life Extension s Healthy Talk Series Managing High Blood Pressure Naturally Michael A. Smith, MD Life Extension s Healthy Talk Series Part 1 What is Blood Pressure? Blood Pressure Systole Systolic Forward Pressure 110 mmhg 70 mmhg Diastole

More information

Adolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center

Adolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center Adolescent Hypertension Roles of obesity and hyperuricemia Daniel Landau, MD Pediatrics, Soroka University Medical Center Blood Pressure Tables BP standards based on sex, age, and height provide a precise

More information

N Engl J Med 2018;378: DOI: /NEJMoa Lin, Wan-Ting 2018/06/27

N Engl J Med 2018;378: DOI: /NEJMoa Lin, Wan-Ting 2018/06/27 N Engl J Med 2018;378:1200-10. DOI: 10.1056/NEJMoa1710895 Lin, Wan-Ting 2018/06/27 1 Introduction Gout is a chronic illness characterized by hyperuricemia, arthropathy, tophus development, and urolithiasis

More information

Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희

Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희 Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희 Introduction Unique characteristics of Fructose Metabolism Mechanism for Fructose-Induced Insulin Resistance Epidemiological Studies

More information

The Independent Association of Serum Retinol and β-carotene Levels with Hyperuricemia A National Population Study

The Independent Association of Serum Retinol and β-carotene Levels with Hyperuricemia A National Population Study Original Article DOI 10.1002/acr.20692 Title: The Independent Association of Serum Retinol and β-carotene Levels with Hyperuricemia A National Population Study Authors: Woo-Joo Choi 1, Earl S. Ford, MD,

More information

Gout Goals Are Not Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools JointsAflame

Gout Goals Are Not Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools JointsAflame Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance QS Priorities Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools TM JointsAflame

More information

Hyperurikaemie - nur Gicht oderauch kardio-renales Risiko?

Hyperurikaemie - nur Gicht oderauch kardio-renales Risiko? 9. November 2017 Hyperurikaemie - nur Gicht oderauch kardio-renales Risiko? PD Dr. Bernhard Hess Innere Medizin & Nephrologie NierensteinZentrum Zürich Hirslanden Kliniken Im Park & Hirslanden, Zürich

More information

The 2010 Competency Standards addressed by this activity include (but may not be limited to): 4.2.2, 4.2.3, 6.1.2, 6.2.1, 7.1.2, 7.1.3,

The 2010 Competency Standards addressed by this activity include (but may not be limited to): 4.2.2, 4.2.3, 6.1.2, 6.2.1, 7.1.2, 7.1.3, UPDATE ON GOUT Learning objectives: After completing this activity, pharmacists should be able to: 1. describe the mechanisms underlying hyperuricaemia 2. state the risk factors for development of gout

More information